These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2411397)

  • 1. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
    Zimm S; Johnson GE; Chabner BA; Poplack DG
    Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.
    Liliemark J; Pettersson B; Engberg B; Lafolie P; Masquelier M; Peterson C
    Cancer Res; 1990 Jan; 50(1):108-12. PubMed ID: 2293545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
    Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
    Zimm S; Reaman G; Murphy RF; Poplack DG
    Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of 6-mercaptopurine to 6-thioguanylic acid in L-1210 cells and human leukemia cells.
    Uchida M; Nakamura T; Uchino H
    Jpn J Cancer Res; 1985 Feb; 76(2):124-30. PubMed ID: 2858424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and metabolism of 2-beta-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture.
    Earle MF; Glazer RI
    Cancer Res; 1983 Jan; 43(1):133-7. PubMed ID: 6182988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
    Zeng H; Lin ZP; Sartorelli AC
    Biochem Pharmacol; 2004 Sep; 68(5):911-21. PubMed ID: 15294454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 6-mercaptopurine in human leukemic cells.
    Higuchi T; Nakamura T; Wakisaka G
    Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities.
    Baskin F; Rosenberg RN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):293-300. PubMed ID: 1169317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
    Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
    Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
    Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
    Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
    Gunnarsdottir S; Elfarra AA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):950-7. PubMed ID: 10454464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative kinetics of poly(6-thioinosinic acid) and 6-mercaptopurine treated L1210 cells.
    Tomasovic SP; Higashikubo R; Cohen AM; Broom AD
    Cytometry; 1982 Jul; 3(1):48-54. PubMed ID: 6889485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.